CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression
Links shared publicly online about this topic.
- 598total visits
CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression
CeNeRx BioPharma, Inc., reported that it has initiated a Phase II trial of its new formulation of TriRima™, the company's novel antidepressant in development as monotherapy for treatment res
View full resource at medicalnewstoday.com
Tags: Depression, Antidepressant
Most Recently Shared on January 7, 2011 at 5:05 pm By:
CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression http://mnt.to/3PJS
Also Shared By:
Phase 2 study of TriRima for treatment resistant depression - ONA
oncologynurseadvisor.com — “CeNeRx BioPharma reported that it has initiated a Phase 2 trial of TriRima as monotherapy for treatment resistant depression.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 6, 2011 at 7:39 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 2 study of TriRima for treatment resistant depression http://goo.gl/fb/7xS2w
Advertisement
MNT Depression News
@mnt_depression
CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression http://mnt.to/3PJS #depression
1 year ago...